NICE, drug-eluting stents and the limits of trial data

Heart

Volumn 95, Issue 6, 2009, Pages 505-506

  Mohindra, R ^a  

^a NONE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CLINICAL TRIAL; COST EFFECTIVENESS ANALYSIS; DATA ANALYSIS; DRUG ELUTING STENT; GOVERNMENT; HEALTH CARE COST; HUMAN; LETTER; PRIORITY JOURNAL; THERAPY EFFECT;

CORONARY RESTENOSIS; COST-BENEFIT ANALYSIS; DRUG-ELUTING STENTS; GREAT BRITAIN; HUMANS; PRACTICE GUIDELINES AS TOPIC; TREATMENT OUTCOME;

EID: 61949136270     PISSN: 13556037     EISSN: 1468201X     Source Type: Journal    
DOI: None     Document Type: Letter

References (4)

1. de Belder MA. NICE guidelines for the use of drug-eluting stents: how do we establish worth? Heart 2008;94:1646-8.
2. Rawlins M, Culyer AJ. National Institute for Clinical Excellence and its value judgments. BMJ 2004;329:224-7.
3. Burke K. NICE needs sweeping changes to maintain credibility, say MPs. BMJ 2002;325:5.
4. Hume D. Treatise on human nature. 1738. Book III part 1. Available at http://oll.libertyfund.org/?option=com-staticxt&staticfile= show.php%3Ftitle=342&chapter=55211&layout=html&Itemid=27 (accessed 17 December 2008).